Peripheral neuropathy in ART-experienced patients: prevalence and risk factors

被引:42
作者
Chen, Huichao [1 ]
Clifford, David B. [2 ]
Deng, Lijuan [1 ]
Wu, Kunling [1 ]
Lee, Anthony J. [1 ]
Bosch, Ronald J. [1 ]
Riddler, Sharon A. [3 ]
Ellis, Ronald J. [4 ]
Evans, Scott R. [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[2] Washington Univ, St Louis, MO USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
关键词
Peripheral neuropathy; Symptomatic peripheral neuropathy; Risk factors; HIV infection; ENHANCED PROTEASE INHIBITORS; SENSORY NEUROPATHY; RANDOMIZED-TRIAL; CCR5; INHIBITOR; HIV NEUROPATHY; AIDS; THERAPY; ASSOCIATION; INFECTION; DISEASE;
D O I
10.1007/s13365-013-0216-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Peripheral neuropathy (PN) is a common neurological complication of HIV infection that has debilitating effects on quality of life. While there has been a comprehensive evaluation of the prevalence of neuropathic signs/symptoms and risk factors (RFs) for PN or symptomatic PN (SPN) with initiation of combination antiretroviral therapy (cART) in ART-naive patients, similar evaluation in ART-experienced patients is limited. This study investigated the prevalence and RFs for PN/SPN in ART-experienced patients enrolled in clinical salvage therapy studies. Between February 2000 and June 2007, 522 ART-experienced participants who experienced virologic failure with a prior regimen and started new regimens were followed longitudinally and annually screened for signs and symptoms of PN. Rates of PN/SPN at 3 years since parent study entry were 52.8 and 24.0 %, respectively. Aging, taller height, protease inhibitor use, and female sex were significant RFs for PN/SPN. The use of statin drugs was significantly associated with lower odds of SPN, and it may prevent progression from no SPN to SPN.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 34 条
[21]   HIV-associated sensory neuropathies [J].
Keswani, SC ;
Pardo, CA ;
Cherry, CL ;
Hoke, A ;
McArthur, JC .
AIDS, 2002, 16 (16) :2105-2117
[22]   Neurological complications of HIV infection [J].
McArthur, JC ;
Brew, BJ ;
Nath, A .
LANCET NEUROLOGY, 2005, 4 (09) :543-555
[23]   Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection [J].
Murphy, RL ;
Gulick, RM ;
DeGruttola, V ;
D'Aquila, RT ;
Eron, JJ ;
Sommadossi, JP ;
Currier, JS ;
Smeaton, L ;
Frank, I ;
Caliendo, AM ;
Gerber, JG ;
Tung, R ;
Kuritzkes, DR .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (04) :808-816
[24]  
Otruba P, 2011, NEUROENDOCRINOL LETT, V32, P688
[25]   HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease [J].
Pardo, CA ;
McArthur, JC ;
Griffin, JW .
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2001, 6 (01) :21-27
[26]   Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: Protease inhibitor-mediated neurotoxicity [J].
Pettersen, JA ;
Jones, G ;
Worthington, C ;
Krentz, HB ;
Keppler, OT ;
Hoke, A ;
Gill, MJ ;
Power, C .
ANNALS OF NEUROLOGY, 2006, 59 (05) :816-824
[27]  
Purwata Thomas Eko, 2011, J Pain Res, V4, P169, DOI 10.2147/JPR.S21751
[28]   Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents? [J].
Schönbeck, U ;
Libby, P .
CIRCULATION, 2004, 109 (21) :18-26
[29]   HIV neuropathy natural history cohort study - Assessment measures and risk factors [J].
Simpson, D. M. ;
Kitch, D. ;
Evans, S. R. ;
McArthur, J. C. ;
Asmuth, D. M. ;
Cohen, B. ;
Goodkin, K. ;
Gerschenson, M. ;
So, Y. ;
Marra, C. M. ;
Diaz-Arrastia, R. ;
Shriver, S. ;
Millar, L. ;
Clifford, D. B. .
NEUROLOGY, 2006, 66 (11) :1679-1687
[30]   THE ASSOCIATION BETWEEN SYMPTOMATIC SENSORY NEUROPATHY AND BODY STATURE IN DIABETIC-PATIENTS [J].
SOSENKO, JM ;
BOULTON, AJM ;
GADIA, MT ;
WARD, JD ;
SKYLER, JS .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1988, 4 (02) :95-98